Olink® Explore 3072
A high-throughput platform offering uncompromised data quality
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Olink® Explore 3072 is a high-throughput protein biomarker discovery platform used to measure the concentration of thousands of human plasma proteins using minute amounts of sample. Explore 3072 comprises our entire library of validated protein assays.
Revolutionizing biomarker research with Olink technology
Hear from Professor Guillaume Paré from McMaster University, as he discusses the critical shift away from the traditional 'one biomarker, one disease' paradigm. He advocates for a more dynamic view of biomarkers, particularly focusing on protein signatures that can support better disease understanding and therapy development.
Olink is paving the way with its PEA technology to support the analysis of 5–5400+ proteins simultaneously. By working with an Olink Certified Service Provider such as CRLB-GMEL headed by Professor Guillaume Paré, investigators are enabled to redefine the boundaries of medical research and gain unique insights into disease biology, aiding the identification of new therapeutic targets and biomarkers.
New insights into human disease that could propel drug development
The largest open-access proteogenomic dataset to date lays the groundwork for the future discovery of novel drug targets and biomarkers
The importance of protein biomarkers in drug development: A roundtable discussion
SelectScience speaks with drug discovery experts to learn how they are using protein biomarkers across different stages of the drug development process
